title: Erectile dysfunction in chronic renal failure patients undergoing hemodialysis in Egypt.
abstract: In clinical practice, the attention given to sexual problems in patients with end-stage renal disease is low. In order to evaluate the erectile function in chronic renal failure patients undergoing hemodialysis (HD) as a renal replacement therapy in upper Egypt, we used the abridged version of the International Index of Erectile Function (IIEF-5). In all, 75 HD patients were subjected to clinical and laboratory investigations. The controls were 948 healthy males representing the general Egyptian population. The prevalence of erectile dysfunction (ED) among the HD patients was 82.5% compared to 30% among controls. The prevalence of ED in HD group was significantly higher than in controls. The prevalence of ED in HD patients <50 y was 80% and it was 88% in those > or =50 y, while the prevalence of ED among controls was 28 and 69.8%, respectively. The prevalence of severe degree of ED was significantly higher in both groups compared to controls, while moderate degree of ED showed a statistical significance compared to controls in age groups <50 y and mild degree of ED showed a statistical significance compared to controls in age groups > or =50 y. [corrected] Age (r=-0.3368, P<0.01), serum urea (r=-0.5974, P<0.001), and creatinine level (r=-0.5804, P<0.001) have a significant negative correlation with the presence of ED among HD patients, while serum hemoglobin (r=0.3396, P<0.001) and years of HD age (r=0.3147, P<0.01) have a significant positive correlation with the presence of ED among the HD patients. In view of the observed high prevalence of ED among the HD patients, we believe that a complete health evaluation of male HD patients should include a discussion about erectile function in the standard clinical care program of patients with renal disease.
authors.affiliation: Department of Dermatology and Andrology, Faculty of Medicine, Assiut University Hospital, Assiut, Egypt.
authors.forename: M-E M
authors.initials: ME
authors.lastname: Ali
authors.forename: H Z
authors.initials: HZ
authors.lastname: Abdel-Hafez
authors.forename: A M
authors.initials: AM
authors.lastname: Mahran
authors.forename: H Z
authors.initials: HZ
authors.lastname: Mohamed
authors.forename: E R
authors.initials: ER
authors.lastname: Mohamed
authors.forename: A M
authors.initials: AM
authors.lastname: El-Shazly
authors.forename: A M
authors.initials: AM
authors.lastname: Gadallah
authors.forename: M A
authors.initials: MA
authors.lastname: Abbas
mesh_terms: D000328:Adult; D000368:Aged; D016022:Case-Control Studies; D003404:Creatinine / Q000097:blood; D004534:Egypt / Q000453:epidemiology; D007172:Erectile Dysfunction / Q000453:epidemiology* / Q000209:etiology; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D006435:Renal Dialysis; D012307:Risk Factors; D012720:Severity of Illness Index; D013997:Time Factors; D014508:Urea / Q000097:blood
chemical_list: D014508:Urea; D003404:Creatinine